HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation slashed for throat cancer in bold new trial
Disease control OngoingThis study is testing whether a much lower dose of radiation, combined with standard chemotherapy, works as well as the current high-dose standard for treating HPV-positive throat cancer. It aims to control the cancer while potentially reducing long-term side effects from radiati…
Matched conditions: HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Doctors test cutting radiation dose for HPV throat cancer
Disease control OngoingThis study is testing whether a shorter course of lower-dose radiation is safe and effective for patients with HPV-related throat cancer who have already had surgery. The goal is to see if reducing radiation can control the cancer while causing fewer side effects and improving qu…
Matched conditions: HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC